| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702529 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
No significant difference in RFS was observed among patients treated with TICE BCG or Connaught BCG in combination with IFN.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ryan L. M.D., Nathan A. M.D., Lewis J. M.D., Sarah L. M.S., Michael A. M.D.,